Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investee Company Update re Yooma and Board Changes

18 May 2020 07:00

RNS Number : 1251N
FastForward Innovations Limited
18 May 2020
 

FastForward Innovations Ltd / AIM: FFWD / Sector: Closed End Investments

 

18 May 2020

FastForward Innovations Ltd

("FastForward", "FFWD" or the "Company")

 

Investee Company Update: Yooma Corp.

and

Board Changes

 

FastForward Innovations Ltd, the AIM quoted company focused on investing in fast growing, industry leading businesses, is pleased to provide an update in respect of investee company Yooma Corp. ('Yooma'), announce the resignation of Lorne Abony as Chairman and CEO of the Company and the appointment of existing directors Ed McDermott as CEO, and Ian Burns as Non-Executive Chairman, with immediate effect.

 

Yooma Corp. Investment and Update

 

FastForward has agreed to invest $1 million in Yooma as part of a $5 million fundraising round at a price of $0.65 per share (the 'Investment'). This follows the sale of Company's holding in Entertainment Direct Asia (trading as 'Yooya') to Yooma (together the "Enlarged Group"), as announced at 23 April 2020. Following the Investment and the sale of its interest in Yooya, FastForward will hold 3,588,078 shares in Yooma, representing 10.65% of the company, with an implied value of $2,332,000 (circa £1.9 million) based on the subscription price of this $5 million fundraise. On a pro forma basis, in the year to 31 December 2019, the Enlarged Group reported revenue of $451,090, a loss before tax of $537,265 and net assets of $353,000.

 

Yooma's business plan includes partnering with some of Pan-Asia's leading social and e-commerce platforms creating the first Hemp and CBD focused lifestyle company in Asia. Initially Yooma will focus on hemp-based wellness products in China, but will expand to include licenced CBD products in new territories as the business develops. Yooma has built what it believes is a high calibre international team of multi-cultural, multi-language industry professionals who specialize in building new to market brands, leveraging live streaming, social media marketing and e-commerce distribution channels.

 

Yooma CEO, Ron Wardle, commented, "We are pleased that FastForward has reaffirmed its commitment to Yooma through its current investment. We believe that Yooma is well positioned to be one of the first entrants into the hemp lifestyle products category in Asia, through various social and e-commerce platforms, which we expect to generate value for all Yooma shareholders."

 

Board Changes

 

Following the Investment, Lorne Abony will be appointed as a Non-Executive Director of Yooma Corp. and will work with the executive team to deliver the Yooma business plan. To pursue his other business interests, the Board of Directors and Mr. Abony have agreed that he will step down as Chairman and CEO of FastForward from today. Mr. Abony has agreed with the Company that he will continue to monitor the Company's interests in Yooma, EMMAC Life Sciences ('EMMAC') (alongside existing director Ed McDermott), Vemo Education ('Vemo') and Leap Gaming, where he is also a director.

 

FastForward is therefore also pleased to announce the appointment of Ed McDermott, previously a Non-Executive Director, as CEO, and the appointment of Ian Burns, also previously a Non-Executive Director, as Non-Executive Chairman, both with immediate effect.

 

Mr. McDermott has circa 15 years' experience in the management, financing, and strategic development of growth companies. He has broad experience in several high growth sectors and, as a finance specialist, has been pivotal in raising over £500 million for public and private companies during his career. Mr. McDermott has been on the Board of FastForward as a Non-Executive Director since February 2018

 

Ian Burns has been a Director of FFWD since November 2014, following a long career in the finance industry in Guernsey and internationally. He is a Fellow of the Institute of Chartered Accountants in England and Wales as well as holding other qualifications in the fiduciary and funds sectors and is personally licensed as a fiduciary by the Guernsey Financial Services Commission.

 

Departing Lorne Abony noted, "The investment in Yooma is the last deal I led as CEO of FastForward. The last 12 months has been a challenging time for the Company and a number of its investee companies but I believe the portfolio is well positioned to deliver value over the short-to-medium term.

 

"EMMAC and Yooma position the Company as the only company on AIM where investors can get an exposure to European medical cannabis and the global hemp and wellness industry. I believe Leap Gaming has established itself as a leader in virtual gaming, and its partnership with IMG is exciting and has the potential to take Leap's business to another level. Portage is back trading in Canada and its price has performed well despite difficult market conditions. Juvenescence is continuing its mission to establish itself as "the" pre-eminent anti aging company, and we look forward to hearing about milestones from its portfolio of projects, and corporate strategy in the coming months. With VEMO I have high hopes that the ISA model will continue to grow and develop and achieve critical scale in the near-term. Lastly, we shall continue to work with Factom to secure its future and deliver on the value of the IP and technology they have developed."

 

FastForward CEO, Ed McDermott, said, "Lorne has been a great mentor to me personally and most importantly a huge supporter of FFWD. He has created an excellent platform for investors of any size to gain exposure to opportunities that are too often reserved for super high net worth investors or venture capital funds, and I am delighted that we will continue to work with him in his capacity as one of our largest shareholders and a director of four of our investee companies, EMMAC Life Sciences, Vemo Education, Leap Gaming and Yooma.

 

"We are excited by the potential of Yooma in taking European and US hemp oil products into the largely untapped Chinese market at a time when the Chinese Government is actively encouraging the continued development of online retail in China. The Yooma team has a unique combination of Asian markets insight, and a successful history of financing, launching, and exiting hemp-related businesses in North America and Europe. "

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

 

* ENDS*

 

 

For further information on the Company please visit www.fstfwd.co or contact:

 

Ed McDermott

Lance de Jersey

FastForward Innovations Ltd

Email: info@fstfwd.co

 

James Biddle

Roland Cornish

Beaumont Cornish Limited

Nomad

 

Tel: +44 (0) 20 7628 3396

 

Jeremy Dickson

Optiva Securities Limited

Broker

 

Tel: +44 (0) 203 411 1881

 

Beth Melluish

Isabel de Salis

St Brides Partners Ltd

Financial PR

 

Tel: +44 (0)20 7236 1177

 

Notes

FastForward innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDEAPSXFDDEEFA
Date   Source Headline
25th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
18th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
11th Feb 20207:00 amRNSUpdated Key Information Document
31st Jan 20201:30 pmRNSInvestee Company Update: Portage Biotech Inc.
8th Jan 20207:00 amRNSDisposal of Interest in Cryptologic Corp
7th Jan 20207:00 amRNSBoard Appointment
3rd Jan 20201:15 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Dec 20197:00 amRNSHalf-year Report
5th Dec 20192:45 pmRNSTR-1 Notification
19th Nov 20197:00 amRNSLorne Abony appointed as Chairman of EMMAC
16th Oct 20197:00 amRNSInvestee Company Update: EMMAC Life Sciences
15th Oct 20197:00 amRNSInvestee Company Update: Factom inc.
10th Oct 20199:25 amRNSResult of 2019 AGM
27th Sep 20194:31 pmRNSDirector Dealing in the Company
27th Sep 20197:00 amRNSInvestee Company Update : Fralis LLC (Leap Gaming)
26th Sep 201911:21 amRNSInvestee Company Update : Cryptologic Corp
16th Sep 201911:52 amRNSTR-1 Notification of major holdings
11th Sep 20198:00 amRNSResults for the year ended 31st March 2019
11th Sep 20198:00 amRNSNotice of 2019 Annual General Meeting
22nd Aug 201912:01 pmRNSDirectorate Change
19th Aug 20199:23 amRNSJuvenescence closes Series B funding
12th Aug 20193:02 pmRNSInvestee Company Update-Cryptologic issues loan
12th Aug 201910:11 amRNSPortage Trading Suspended
6th Aug 20194:42 pmRNSInvestee Company Update: Cryptologic Corp
30th Jul 201911:07 amRNSSAFE Agreement with Factom, Inc. Extended
25th Jul 20198:17 amRNSFactom Inc SAFE Agreement temporary extension
18th Jul 201911:20 amRNSInvestee Company Update: Regent Pacific on Yooya
16th Jul 20199:13 amRNSInvestee Company Update:EMMAC acquires Terre Verde
11th Jul 20193:00 pmRNSDisposal of interest in Intensity Therapeutics Inc
9th Jul 201910:51 amRNSInvestee Company Update: EMMAC enters new Market
26th Jun 20198:56 amRNSInvestee Company Update: Intensity Therapeutics
29th May 20193:43 pmRNSInvestee Company Update: Offer for Yooya
13th May 201910:21 amRNSDisposal of interest in Vemo Education Inc.
18th Apr 20197:00 amRNSInvestee Company Update: Intensity Therapeutics
4th Apr 20199:51 amRNSTR1 - Correction
3rd Apr 20194:00 pmRNSTR:1 Regent Mercantile Holdings Limited
20th Mar 201911:00 amRNSCompletion of £2 million investment in EMMAC
7th Mar 20194:03 pmRNS£2 million investment in EMMAC Life Sciences
15th Jan 20193:45 pmRNSJuvenescence Series B Funding
3rd Jan 201911:47 amRNSBoard Appointment
12th Dec 201812:52 pmRNSHalf-year Report
3rd Dec 20187:00 amRNSInvestee Company Update: Factom and Yooya
14th Nov 20181:31 pmRNSInvestee Company Update: Factom Inc
22nd Oct 201812:24 pmRNSIntensity Therapeutics Inc Update
12th Sep 20186:12 pmRNSResult of AGM
10th Sep 20189:16 amRNSHolding(s) in Company
22nd Aug 20188:08 amRNSDirector Dealing
3rd Aug 201812:48 pmRNSShareholder update
3rd Aug 20188:00 amRNSPlacing
1st Aug 201812:05 pmRNSResponse to Media Speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.